Manifestações dermatológicas em pacientes oncológicos atendidos em um projeto de extensão universitária
Dermatological manifestations in oncology patients treated in a university extension project
DOI:
https://doi.org/10.5380/ef.v1i39.103136Keywords:
University Extension, Integrative Oncology, Physiotherapy, Health Human Resource Training, Delivery of Health CareAbstract
Dermatological manifestations resulting from cancer treatment negatively affect a patient's quality of life and functional capacity, requiring multidisciplinary actions within the scope of comprehensive health care. In this context, university extension projects in dermatofunctional physiotherapy represent relevant strategies for specialized care delivery, student training, and the production of applied knowledge aligned with the realities of health services. The study aimed to describe the clinical and sociodemographic profile of oncology patients treated in a university extension project in dermatofunctional physiotherapy, with emphasis on the main skin manifestations associated with antineoplastic treatment. This retrospective cross-sectional study was developed through the analysis of medical records of patients treated free of charge in a university extension project at the Federal University of Paraná. A total of 45 medical records were analyzed, considering sociodemographic, clinical, and dermatological variables. The sample consisted predominantly of women (95,5%), with a mean age of 46,9 ± 12,7 years, and a higher prevalence of breast cancer (57,7). Chemotherapy was the most frequently reported oncological treatment (66,6%), followed by surgery (48,8%) and radiotherapy (46,6%). The most prevalent skin manifestations were xerosis (62,2%), edema (60,0%), altered sensation (48,8%), hair loss (41,9%), and skin scaling (40,0%). The findings indicate a high demand for dermatofunctional care in the oncological context and reinforce the role of university extension as a strategy for health care delivery, professional training, and the integration of teaching, research, and community engagement, contributing to improved quality of life among oncology patients.
Downloads
References
ABUSANAD, A. M.; CHERFANE, M.; AKLHAVAT, D.; KAFROUNY, R.; BOUKHALIL, T. Onco-dermatologic care and quality of life in cancer patients: insights from a Middle Eastern cohort. JCO Oncology Practice, Alexandria, v. 21, p. 348–348, 2025. DOI: https://doi.org/10.1200/OP.2025.21.10_suppl.348.
ALMEIDA, V.; PIRES, D.; SILVA, M.; TEIXEIRA, M.; TEIXEIRA, R. J.; LOURO, A.; DINIS, M. A. P.; FERREIRA, M.; TEIXEIRA, A. Dermatological side effects of cancer treatment: psychosocial implications – a systematic review of the literature. Healthcare, Basel, v. 11, n. 19, p. 2621, 2023. DOI: https://doi.org/10.3390/healthcare11192621.
ARAÚJO, I. F.; AGUIAR, B. R.; FERREIRA, G. F.; ARANTES, A. M. B. Perfil clínico-epidemiológico de pacientes oncológicos em cuidados paliativos: um estudo retrospectivo. Brasília Médica, Brasília, v. 58, p. 1–7, 2021. DOI: https://doi.org/10.5935/2236-5117.2021v58a26.
BARBOSA, B. R. M.; SILVA, L. A.; DUMAS, F. L. V. Perfil sociodemográfico, clínico e funcional dos pacientes oncológicos atendidos pela fisioterapia em um serviço de atenção domiciliar. Health Residencies Journal, v. 5, n. 23, p. 18–25, 2024. DOI: https://doi.org/10.51723/hrj.v5i23.975.
BERRETTA, M.; QUAGLIARIELLO, V.; OTTAIANO, A.; SANTORSOLA, M.; DI FRANCIA, R.; CARROCCIO, P.; MAUREA, N.; BUONOMO, O. C.; FACCHINI, G.; DI MAURO, G.; MONTOPOLI, M.; TOSCANO, E.; GELSOMINO, C.; PICONE, A.; FRANCHINA, T.; MUSCOLINO, P.; BIGNOCOLO, A.; VANNI, G.; CIAPPINA, G.; MONTELLA, L. Multidisciplinary integrative medicine approach for cancer patients: a multicenter retrospective study. Nutrients, Basel, v. 17, n. 6, p. 1012, 2025. DOI: https://doi.org/10.3390/nu17061012.
CEGLIO, W. Q. G. W.; REBEIS, M. M.; SANTANA, M. F.; MIYASHIRO, D.; CURY-MARTINS, J.; SANCHES, J. A. Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital. Anais Brasileiros de Dermatologia, Rio de Janeiro, v. 97, n. 1, p. 14–21, 2022. DOI: https://doi.org/10.1016/j.abd.2021.05.007.
CURY-MARTINS, J.; ERIS, A. P. M.; ABDALLA, C. M. Z.; SILVA, G. B.; MOURA, V. P. T.; SANCHES, J. A. Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel. Anais Brasileiros de Dermatologia, Rio de Janeiro, v. 95, n. 2, p. 221–237, 2020. DOI: https://doi.org/10.1016/j.abd.2020.01.001
DANTAS, M.P.; DE ALBUQUERQUE, M.H.M; SOUSA, L.H.S; TOMAZ, V. R.; SILVA, J.I.; DE MEDEIROS, S.B.L.; DE AVILA, C.B.; AGUIAR, L.D.; NEPOMUCENO, M.M. Pluralidade do cuidar: a saúde em contexto de interculturalidade. Extensão em Foco, [S. l.], n. 30, 2023. DOI: 10.5380/ef.v0i30.82660.
DEUTSCH, A.; LEBOEUF, N. R.; LACOUTURE, M. E.; MCLELLAN, B. N. Dermatologic adverse events of systemic anticancer therapies: cytotoxic chemotherapy, targeted therapy, and immunotherapy. American Society of Clinical Oncology Educational Book, 40, 485–500. https://doi.org/10.1200/EDBK_289911
DRENO, B.; KHOSROTEHRANI, K.; DE BARROS SILVA, G.; WOLF, J. R.; KEROB, D.; TROMBETTA, M.; ATENGUENA, E.; DIELENSEGER, P.; PAN, M.; SCOTTE, F.; KRAKOWSKI, I.; LACOUTURE, M. The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus. Supportive Care in Cancer, Heidelberg, v. 31, n. 12, p. 672, 2023. DOI: https://doi.org/10.1007/s00520-023-08116-4
DUECK, A. C.; THANARAJASINGAM, G.; ROGAK, L.; MAZZA, G. L.; LANGLAIS, B. T.; NOBLE, B. N.; GINOS, B. F.; MEAD-HARVEY, C.; YEE, C. I.; LEE, M. K.; DEAL, A. M.; MEEK, E. A.; BASCH, E. Methods for implementing and reporting the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient-reported adverse events in cancer clinical trials. Cancer, Hoboken, v. 131, supl. 2, e35951, 2025. DOI: https://doi.org/10.1002/cncr.35951
DUYGU-YILDIZ, E.; BAKAR, Y.; HIZAL, M. The effect of complex decongestive physiotherapy applied with different compression pressures on skin and subcutaneous tissue thickness in individuals with breast cancer-related lymphedema: a double-blinded randomized comparison trial. Supportive Care in Cancer, Heidelberg, v. 31, n. 7, p. 383, 2023. DOI: https://doi.org/10.1007/s00520-023-07843-y.
FALCÓN GONZÁLEZ, A.; GALLEGOS SANCHO, M. I.; GONZÁLEZ FLORES, E.; GALVE CALVO, E.; RUIZ VOZMEDIANO, J.; DOMINGO GARCÍA, P.; LÓPEZ MARTOS, R.; SÁNCHEZ RIVAS, E.; IGLESIAS URRACA, C. M.; GÓMEZ CALVO, A. I.; DE MARISCAL POLO, A.; RAMOS-MEDINA, R.; RIVERO, M.; MARTÍNEZ MARÍN, V. Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients. Clinical and Translational Oncology, Cham, v. 27, n. 3, p. 909–934, 2025. DOI: https://doi.org/10.1007/s12094-024-03636-9
FERNÁNDEZ-MARTÍN, M. E.; TARAZONA, J. V.; HERNÁNDEZ-CANO, N.; IBARGUREN, A. M. The importance of cosmetics in oncological patients: survey of tolerance of routine cosmetic care in oncological patients. Cosmetics, Basel, v. 12, p. 137, 2025. DOI: https://doi.org/10.3390/cosmetics12040137.
GOBBO, M.; RICO, V.; MARTA, G. N.; CAINI, S.; WOLF, J. R.; VAN DEN HURK, C.; BEVERIDGE, M.; LAM, H.; BONOMO, P.; CHOW, E.; BEHROOZIAN, T. Photobiomodulation therapy for the prevention of acute radiation dermatitis: a systematic review and meta-analysis. Supportive Care in Cancer, Heidelberg, v. 31, n. 4, p. 227, 2023. DOI: https://doi.org/10.1007/s00520-023-07673-y
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC). Global Cancer Observatory (GLOBOCAN 2024): Cancer today. Lyon: WHO/IARC, 2024. Disponível em: https://gco.iarc.fr/today. Acesso em: 25/10/2025.
ILIESCU, M. G.; STANCIU, L. E.; UZUN, A. B.; CRISTEA, A. E.; MOTOAȘCĂ, I.; IRSAY, L.; ILIESCU, D. M.; VARI, T.; CIUBEAN, A. D.; CARABAN, B. M.; CIUFU, N.; AZIS, O.; CIORTEA, V. M. Assessment of integrative therapeutic methods for improving the quality of life and functioning in cancer patients: a systematic review. Journal of Clinical Medicine, Basel, v. 13, n. 5, p. 1190, 2024. DOI: https://doi.org/10.3390/jcm13051190
INSTITUTO NACIONAL DE CÂNCER (INCA). Estimativa 2023–2025: incidência de câncer no Brasil. Rio de Janeiro: INCA, 2023. Disponível em: https://www.gov.br/inca. Acesso em: 25/10/2025.
KLUETZ, P. G.; CHINGOS, D. T.; BASCH, E. M.; MITCHELL, S. A. Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). American Society of Clinical Oncology Educational Book, Alexandria, v. 35, p. 67–73, 2016. DOI: https://doi.org/10.1200/EDBK_159514
LACOUTURE, M. E.; SIBAUD, V.; GERBER, P. A.; VAN DEN HURK, C.; FERNÁNDEZ-PEÑAS, P.; SANTINI, D.; JAHN, F.; JORDAN, K. Prevention and management of dermatological toxicities related to anticancer agents: ESMO clinical practice guidelines. Annals of Oncology, Oxford, v. 32, n. 2, p. 157–170, 2021. DOI: https://doi.org/10.1016/j.annonc.2020.11.005.
LADWA, R.; FOGARTY, G.; CHEN, P.; GREWAL, G.; MCCORMACK, C.; MAR, V.; KEROB, D.; KHOSROTEHRANI, K. Management of skin toxicities in cancer treatment: an Australian/New Zealand perspective. Cancers, Basel, v. 16, n. 14, p. 2526, 2024. DOI: https://doi.org/10.3390/cancers16142526
LESTIDO, V.; RODRÍGUEZ, F.; RODRÍGUEZ, A.; POMBO, V.; BARRIOS, R.; PAVANI, C. Photobiomodulation in the treatment of palmar-plantar erythrodysesthesia: a randomised controlled clinical study protocol. BMJ Open, London, v. 14, n. 4, e081459, 2024. DOI: https://doi.org/10.1136/bmjopen-2023-081459.
MAIA, A. E. S.; GRELLO, F. A. de C. G.; CUNHA, K. da C. Perfil sociodemográfico e clínico de pacientes com câncer cadastrados no programa de visita domiciliar de um hospital da rede pública. Revista Brasileira de Cancerologia, Rio de Janeiro, v. 67, n. 2, e-05864, 2021. DOI: https://doi.org/10.32635/2176-9745.RBC.2021v67n2.864.
MAO, J. J.; PILLAI, G. G.; ANDRADE, C. J.; LIGIBEL, J. A.; BASU, P.; COHEN, L.; KHAN, I. A.; MUSTIAN, K. M.; PUTHIYEDATH, R.; DHIMAN, K. S.; LAO, L.; GHELMAN, R.; CÁCERES GUIDO, P.; LOPEZ, G.; GALLEGO-PEREZ, D. F.; SALICRUP, L. A. Integrative oncology: addressing the global challenges of cancer prevention and treatment. CA: A Cancer Journal for Clinicians, Hoboken, v. 72, n. 2, p. 144–164, 2022. DOI: https://doi.org/10.3322/caac.21706
McEVOY, M. P.; FELDMAN, S. Prevention and treatment of lymphedema in breast cancer. Advances in Surgery, Philadelphia, v. 58, n. 1, p. 65–77, 2024. DOI: https://doi.org/10.1016/j.yasu.2024.04.005.
McEVOY, M. P.; RAVETCH, E.; PATEL, G.; FOX, J.; FELDMAN, S. Prevention of breast cancer-related lymphedema. Clinical Breast Cancer, New York, v. 21, n. 2, p. 128–142, 2021. DOI: https://doi.org/10.1016/j.clbc.2021.02.009
McNEELY, M. L.; SHALLWANI, S. M.; AL ONAZI, M. M.; LURIE, F. The effect of compression therapies and therapeutic modalities on lymphedema secondary to cancer: a rapid review and evidence map. Medical Oncology, Londres, v. 41, n. 11, p. 288, 2024. DOI: https://doi.org/10.1007/s12032-024-02447-w.
MIRANDA, J. F.; ARAÚJO, M. P.; OLIVEIRA, K. G. Z. The man in search of primary health care services in the city of Imperatriz-MA. Research, Society and Development, Itabira, v. 11, n. 1, e56011124946, 2022. DOI: https://doi.org/10.33448/rsd-v11i1.24946.
MOURELLE, M. L.; GÓMEZ, C. P.; LEGIDO, J. L. Cosmeceuticals and thalassotherapy: recovering the skin and well-being after cancer therapies. Applied Sciences, Basel, v. 13, p. 850, 2023. DOI: https://doi.org/10.3390/app13020850.
PARRIEL, E.; SIBAUD, V. Supportive oncodermatology is the key! Journal of the European Academy of Dermatology and Venereology, Oxford, v. 38, n. 9, p. 1675–1676, 2024. DOI: https://doi.org/10.1111/jdv.20228.
PÉREZ, D. A.; ACOSTA MADIEDO, A. S.; ANDREANI, S.; ANDRIESSEN, A.; CÁRDENAS, H.; MORENO, M.; MOTOLA KUBA, D.; RIGANTI, J.; ENRIQUE OLLAGUE, J.; LACOUTURE, M.; TOQUICA, A. Latin America cutaneous oncology management (LACOM) I: the role of skin care in oncology patients and survivors. Journal of Drugs in Dermatology, Nova Iorque, v. 24, n. 3, p. 262–268, 2025. DOI: https://doi.org/10.36849/JDD.8565.
RA, H. S.; SHIN, S. J.; KIM, J. H.; LIM, H.; CHO, B. C.; ROH, M. R. The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients. Journal of the European Academy of Dermatology and Venereology, Oxford, v. 27, n. 1, p. e53–e59, 2013. DOI: https://doi.org/10.1111/j.1468-3083.2012.04466.x.
RAO, D.; DSOUZA, C. N.; PRABHU, S. S.; KUMAR, P.; PRABHU, V. Photobiomodulation therapy for mitigating severity of radiodermatitis in cancer patients undergoing radiotherapy: a scoping review. Supportive Care in Cancer, Heidelberg, v. 32, n. 11, p. 750, 2024. DOI: https://doi.org/10.1007/s00520-024-08944-y.
ROBIJNS, J.; LODEWIJCKX, J.; CLAES, S.; VAN BEVER, L.; PANNEKOEKE, L.; CENSABELLA, S.; BUSSÉ, L.; COLSON, D.; KAMINSKI, I.; BROUX, V.; PUTS, S.; VANMECHELEN, S.; TIMMERMANS, A.; NOÉ, L.; BULENS, P.; GOVERS, M.; MAES, A.; MEBIS, J. Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial). Radiotherapy and Oncology, Amsterdã, v. 158, p. 268–275, 2021. DOI: https://doi.org/10.1016/j.radonc.2021.03.002.
ROBIJNS, J.; NAIR, R. G.; LODEWIJCKX, J.; ARANY, P.; BARASCH, A.; BJORDAL, J. M.; BOSSI, P.; CHILLES, A.; CORBY, P. M.; EPSTEIN, J. B.; ELAD, S.; FEKRAZAD, R.; FREGNANI, E. R.; GENOT, M. T.; IBARRA, A. M. C.; HAMBLIN, M. R.; HEISKANEN, V.; HU, K.; KLASTERSKY, J.; LALLA, R.; LATIFIAN, S.; MAIYA, A.; MEBIS, J.; MIGLIORATI, C. A.; MILSTEIN, D. M. J.; MURPHY, B.; RABER-DURLACHER, J. E.; ROSEBOOM, H. J.; SONIS, S.; TREISTER, N.; ZADIK, Y.; BENSADOUN, R. J. Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022. Frontiers in Oncology, Lausanne, v. 12, e927685, 2022. DOI: https://doi.org/10.3389/fonc.2022.927685
ROSSI, A. M.; HIBLER, B. P.; NAVARRETE-DECHENT, C.; LACOUTURE, M. E. Restorative oncodermatology: diagnosis and management of dermatologic sequelae from cancer therapies. Journal of the American Academy of Dermatology, St. Louis, v. 85, n. 3, p. 693–707, 2021. DOI: https://doi.org/10.1016/j.jaad.2020.08.005
SALES, P. V. A.; GODÓI, I. P. D.; BRITO, G. A. C.; LEITÃO, R. C.; ARAÚJO, A. A.; MEDEIROS, C. A. C. X. Mechanisms of photobiomodulation therapy in treating and preventing antineoplastic-induced oral mucositis: a systematic review. Acta Cirúrgica Brasileira, São Paulo, v. 40, e403125, 2025. DOI: https://doi.org/10.1590/acb403125.
SAUDER, M. B.; ADDONA, M.; ANDRIESSEN, A.; BUTLER, M.; CLAVEAU, J.; FUGAS, N.; HIJAL, T.; IANNATTONE, L.; KALIA, S.; TEAGUE, L.; LYNDE, C. W. The role of skin care in oncology patients. Skin Therapy Letter, Vancouver, v. 25, supl. B, p. 1–8, 2020.
VAEZ-GHARAMALEKI, Y.; AKBARZADEH, M. A.; JADIDI-NIARAGH, F.; MAHMOODPOOR, A.; SANAIE, S.; HOSSEINI, M. S. Dermatologic toxicities related to cancer immunotherapy. Toxicology Reports, Amsterdam, v. 14, p. 102021, 2025. DOI: https://doi.org/10.1016/j.toxrep.2025.102021.
VALENÇA, T.D.C; DIAS, G. A.; CRUZ, G. S.; SILVA, L.W.S; REIS JÚNIOR, L.S; SANTOS, A.S.; SOUZA, M.Q.; PINHEIRO, K.L.S. RELATO DE EXPERIÊNCIA DE DISCENTES NO CUIDADO FISIOTERAPÊUTICO DE IDOSOS COM DOENÇAS REUMÁTICAS. Extensão em Foco, [S. l.], n. 22, 2021. DOI: 10.5380/ef.v0i22.75291.
VERBELEN, H.; TJALMA, W.; DOMBRECHT, D.; GEBRUERS, N. Breast edema, from diagnosis to treatment: state of the art. Archives of Physiotherapy, Londres, v. 11, n. 1, p. 8, 2021. DOI: https://doi.org/10.1186/s40945-021-00103-4
VISCUSE, P. V.; PRICE, K.; MILLSTINE, D.; BHAGRA, A.; BAUER, B.; RUDDY, K. J. Integrative medicine in cancer survivors. Current Opinion in Oncology, Filadélfia, v. 29, n. 4, p. 235–242, 2017. DOI: https://doi.org/10.1097/CCO.0000000000000376.
WILLIAMS, L. A.; GINEX, P. K.; EBANKS, G. L.; GANSTWIG, K.; CICCOLINI, K.; KWONG, B. K.; ROBISON, J.; SHELTON, G.; STRELO, J.; WILEY, K.; MALONEY, C.; MORIARTY, K. A.; VRABEL, M.; MORGAN, R. L. ONS guidelines™ for cancer treatment–related skin toxicity. Oncology Nursing Forum, Pittsburgh, v. 47, n. 5, p. 539–556, 2020. DOI: https://doi.org/10.1188/20.ONF.539-556
ZHANG, Z.; ZHU, M.; JIANG, W. Risk factors analysis of cutaneous adverse drug reactions caused by targeted therapy and immunotherapy drugs for oncology and establishment of a prediction model. Clinical and Translational Science, Hoboken, v. 18, n. 1, e70118, 2025. DOI: https://doi.org/10.1111/cts.70118
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Gabriella Protovava Santos, Marina Lopes Kramar, Giulianna Costa Escomação, Franciele Cristina Mesquita, Isabel Luiza Piatti, Raciele Ivandra Guarda Korelo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright in articles published in this journal rests with the author, with first publication rights to the journal. As a result of being published in this open access journal, the articles are free to use, and any part of the publications may be reproducing provided that proper credit is given.
All articles published in the Journal Extensão em Foco are under CC BY 4.0 International license.
